You are here

BioCardia

Emory begins enrolment for BioCardia’s trial of ischemic heart failure therapy

Clinical Trials Arena

Mon, 04/14/25 - 10:45 am

clinical trials

ischemic heart failure

ACC 25: Biocardia’s CardiAMP trial fails but cell therapy potential remains

Clinical Trials Arena

Tue, 04/1/25 - 11:34 am

heart failure with reduced ejection fraction

BioCardia rejigs phase 3 heart failure data to find a path forward for cell therapy

Fierce Biotech

Mon, 03/4/24 - 11:43 pm

clinical trials

Myocardial Infarction: Three drug trials to watch in 2024

Clinical Trials Arena

Thu, 02/29/24 - 11:07 am

clinical trials

myocardial infarction

Thrombolytic Science

BioCardia’s Cell Therapy Unlikely to Meet Primary Endpoint in Phase III Heart Failure

BioSpace

Thu, 09/7/23 - 09:33 am

clinical trials

Biocardia takes a pause for thought

EP Vantage

Tue, 07/25/23 - 10:05 am

stem cell therapy

Bayer’s BlueRock inks cardiovascular cell therapy delivery deal

Fierce Pharma

Wed, 08/31/22 - 10:22 am

BlueRock Therapeutics

BioCardia Fills in a Key Piece of CardiaAmp Puzzle with New Clearance

Medical Devices and Diagnostics Industry

Mon, 01/20/20 - 10:58 am

DNA deflectable guide catheter

BioCardia touts preliminary data from heart failure trial

Drug Delivery Business News

Thu, 08/23/18 - 10:17 pm

BioCardia PH III CardiAMP Heart Failure Trial Discussed in American Heart Journal

CP Wire

Mon, 04/9/18 - 09:15 am

clinical trials

BioCardia PH III CardiAMP Heart Failure Trial Discussed in American Heart Journal

Mon, 04/9/18 - 09:13 am